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Abstract 
A large intronic hexanucleotide repeat expansion (GGG GCC ) within the C9orf72 (C9orf72‑SMCR8 Complex Subunit) 
locus is the most prevalent genetic cause of both Frontotemporal Dementia (FTD) and Motor Neuron Disease (MND). 
In patients this expansion is typically hundreds to thousands of repeat units in length. Repeat associated non‑AUG 
translation of the expansion leads to the formation of toxic, pathological Dipeptide‑Repeat Proteins (DPRs). To date 
there remains a lack of in vivo models expressing C9orf72 related DPRs with a repeat length of more than a few 
hundred repeats. As such our understanding of how physiologically relevant repeat length DPRs effect the nervous 
system in an ageing in vivo system remains limited. In this study we generated Drosophila models expressing DPRs 
over 1000 repeat units in length, a known pathological length in humans. Using these models, we demonstrate each 
DPR exhibits a unique, age‑dependent, phenotypic and pathological profile. Furthermore, we show co‑expression of 
specific DPR combinations leads to distinct, age‑dependent, phenotypes not observed through expression of single 
DPRs. We propose these models represent a unique, in vivo, tool for dissecting the molecular mechanisms implicated 
in disease pathology, opening up new avenues in the study of both MND and FTD.
Keywords: Drosophila, Frontotemporal dementia, FTD, MND, Dipeptide‑repeats, C9orf72, ALS
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which 
permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the 
original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or 
other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line 
to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory 
regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this 
licence, visit http://creat iveco mmons .org/licen ses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creat iveco 
mmons .org/publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Introduction
Frontotemporal dementia (FTD) is a common form of 
early-onset dementia. It is clinically and pathologically 
heterogeneous and can co-occur with motor neuron 
disease (MND). It has a strong genetic association with 
up to 40% of patients presenting with a family history of 
disease [25]. The most prevalent genetic cause of FTD, 
identified to date, is an intronic hexanucleotide repeat 
expansion (GGG GCC ) within the C9orf72 (C9orf72-
SMCR8 Complex Subunit) locus [23]. In patients this 
expansion is typically greater than 500, and commonly 
thousands of, repeats in length. In unaffected individu-
als there are usually fewer than 25 repeats [1, 5, 31]. This 
mutation has also been identified as a common cause of 
MND, leading to the view that FTD and MND represent 
a clinical and pathological spectrum of a single disease 
[6].
The molecular mechanisms of neurodegeneration asso-
ciated with the C9orf72 hexanucleotide expansion have yet 
to be fully elucidated. However, three potential, not nec-
essarily mutually exclusive, hypotheses currently exist: 1/
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the hexanucleotide expansion leads to haploinsufficiency 
of the C9orf72 gene, 2/transcription of the expansion leads 
to the formation of toxic RNA foci and 3/non-canonical, 
non-AUG translation of repeat RNA leads to the forma-
tion of toxic dipeptide repeat proteins (DPRs) (Poly-GA, 
Poly-AP, Poly-PR, Poly-GR and Poly-GP). While it is pos-
sible that all three of these mechanisms contribute towards 
disease, studies have shown that C9orf72 knockout models 
fail to recapitulate FTD or MND phenotypes, suggesting 
that even though haploinsufficiency may potentiate toxic 
RNA and DPR gain-of-function it is unlikely to precipitate 
the disease in its own right [4, 10]. Although the contri-
bution of each gain-of-function hypothesis has yet to be 
fully determined a number of crucial studies have dem-
onstrated that DPRs may be the most significant driver of 
neurodegeneration [17, 30, 32].
Current Drosophila models of C9orf72 related DPRs 
have proven beneficial in dissecting the molecular mecha-
nisms contributing towards neurodegeneration in FTD 
and MND. However, recent observations that the patho-
logical properties of DPRs alter with length suggests that 
shorter repeat models may not fully recapitulate disease 
mechanisms [2, 19, 31]. Current Drosophila models may, 
therefore, be limited by their relatively short repeat length, 
the longest being 100 repeats. A number of these models 
also show disproportionate levels of toxicity, relative to 
that observed in patients, and so may not truly recapitulate 
disease. For example, many of these models are lethal when 
DPRs are expressed solely in the fly eye and require an 
inducible expression system to allow them to be expressed 
in the nervous system as viable, if short lived, adult flies. 
It is unclear whether this excessive toxicity is a result of 
the short nature of the repeats, perhaps allowing them 
to be more rapidly translated or to aggregate in a specific 
manner, or due to expression levels associated with the 
genomic location of the inserted transgene. The difficulties 
associated with the methodology of generating and main-
taining long-repeats in in  vivo models, coupled with the 
challenges of appropriate expression levels has typically 
precluded the use of full length DPR models in vivo. The 
significant toxicity of short repeat Drosophila models has 
also prevented the study of DPR toxicity during the ageing 
process, when continuously expressed throughout the fly’s 
lifetime, and when co-expressed. In this study we present 
novel Drosophila models expressing DPRs more than 1000 
repeats in length. These animals exhibit age related motor 
decline and neurodegeneration when expressed through-
out the lifetime of the fly, providing a more representative 
model of disease. Using these models, we demonstrate that 
not only do different DPRs display distinct, assay- and age- 
dependent, phenotypic and pathological profiles but that 
certain phenotypes are only observed when specific DPRs 
are co-expressed and flies aged.
Materials and methods
Drosophila stocks and maintenance
Drosophila were raised on standard cornmeal–
yeast–sucrose medium at 25  °C on a 12  h light:dark 
cycle. Neuronal Synaptobrevin (nSyb)-Gal4 
(RRID:BDSC_51635), Upstream activator sequence 
(UAS)-mCD8-GFP (RRID:BDSC_32184), Tubulin-Gal4 
(RRID:BDSC_5138), OK6-Gal4 (RRID:BDSC_64199), 
UAS-(AP)36 (RRID:BDSC_58695) and UAS-(AP)100 
(RRID:BDSC_58699) stocks were obtained from the 
Bloomington Drosophila Stock Center (BDSC). Glass 
Multimer Reporter (GMR)-Gal4 flies were a gift from 
Sean T. Sweeney (York, UK). nSyb-Gal4/CyO-GFP flies 
were a gift from Chris Elliott (York, UK). UAS-(AP)50 
flies were a gift from Ludo Van Den Bosch (Leuven) [3]. 
UAS-(GR)50 flies were a gift from Craig Bennett (Lin-
coln) [7]. All 1000 repeat DPR stocks were generated 
as part of this study. Unless stated all experiments were 
performed using pan-neuronal expression (nSyb-Gal4, 
RRID:BDSC_51635) at 25 °C. All “wild types” are Canton 
S outcrossed to w1118. All experiments were performed 
using flies from at least 3 independent crosses. Experi-
mental genotypes for each experimental figure are listed 
in Additional file 1: Online resource 1.
Generation of DPR Drosophila lines
DPR constructs generated using semi-randomized alter-
native codons, described previously [2], were sub-cloned 
from the pEGFP-N1 vector (ClonTech) into pUASt-attB 
using EcoRI and XbaI restriction sites to maintain the 
EGFP tag. Alternative codon sequences can be found in 
Bennion Callister et  al. (2016) [2] and Additional file  1: 
Online resource 2. Each dipeptide (e.g. GA) represents 
one repeat unit (6 base pairs, 2 amino acids). Repeat 
lengths for each DPR are AP:1024 repeat units, GA:1020, 
PR:1100, GR:1136 (See Bennion Callister et al. [2]). Each 
construct of ~ 1000 repeat units is followed by a C-Ter-
minal EGFP tag, in frame. For simplicity these constructs 
are referred to simply as 1000 repeat DPRs throughout 
(e.g. UAS-(AP)1000-EGFP is referred to as AP1000). Pre-
vious studies from both ourselves [2] and others have 
shown no effect of the GFP-tag upon DPR localisation or 
pathology. Constructs were validated by sequencing each 
end of the repeat region using pUASt and EGFP primers 
and by agarose gel electrophoresis following restriction 
digest with both EcoRI and BamHI (repeat region) and 
EcoRI and XbaI (repeat region + EGFP). Micro-injection 
of the pUASt-attB-DPR-EGFP constructs into M{vas-int.
DM}ZH-2A;PBac{y[+]-attP-9A}VK00005 Drosophila 
embryos allowed PhiC31-mediated integration of each 
UAS-DPR-EGFP into identical genomic locations. Micro-
injection was performed by the University of Cambridge 
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Department of Genetics Fly Facility. Positive transfor-
mants were identified using the presence of an eye colour, 
resulting from by the pUASt mini-white element. Follow-
ing the generation of balanced, stable stocks from each 
of the transformants all the lines were screened to con-
firm both the presence and length of the DPR construct. 
Southern blotting was used to identify lines carrying full 
length DPR constructs and to monitor DPR stability.
Southern blotting
DNA was extracted from ~ 50 adult heads using protein-
ase K digestion (10 mg/ml in proteinase K buffer; 1 µl per 
head) and phenol–chloroform extraction. Genomic DNA 
was digested using Dde1 and NIaIII restriction enzymes 
(NEB). DNA from Canton-S flies was used as a negative 
control and DNA spiked with ~ 150  ng of DPR positive 
vector per 1 ug of genomic DNA was used as a positive 
control. Following agarose gel electrophoresis of the sam-
ples the gel was depurinated (10 min, 0.25 M HCl), dena-
tured (30 min, 0.6 M NaCl, 0.2 M NaOH) and neutralised 
(30 min, 1.5 M NaCl, 0.5 M Tris–HCl pH8.0). Following 
equilibration of the gel (20  min, SSC buffer; 3  M NaCl, 
300 mM Sodium citrate pH 7.4) it was assembled in the 
southern blotting apparatus and left to transfer onto 
nylon membrane overnight at room temperature. The fol-
lowing day the blot was disassembled and the membrane 
gently washed in 2 × SSC before UV fixation. The mem-
brane was pre-hybridised in DIG easy hyb (Roche) with 
3000 µg of freshly denatured salmon sperm DNA (4 h at 
42 °C with rotation) before hybridisation in DIG easy hyb 
with 1500 µg freshly denatured salmon sperm and 75 ng 
of the appropriate oligo probe (GA probe: DIG-GGC 
AGG AGC TGG AGC TGG CGC AGG AGC TGG TGC TGG 
G-DIG, GR probe: DIG-AGG CAG AGG TCG TGG GAG 
AGG CAG GGG TCG CGG ACG TGGA-DIG, AP probe: 
DIG-AGC ACC AGC ACC GGC GCC AGC TCC AGC ACC 
AGC ACC C-DIG, PR probe: DIG-AGA CCC CGT CCT 
CGT CCT CGT CCA AGA CCA AGG CCG AGGC-DIG). 
The membrane was hybridised overnight at 42  °C. Post 
hybridisation the membrane was washed (3 × 15  min 
2xSSC; 0.1% Sodium dodecyl sulphate (SDS), 65  °C fol-
lowed by 15 min 0.5 × SSC; 0.1% SDS), briefly rinsed in 
maleic acid wash buffer (DIG Wash and Block Buffer Set, 
Roche) and then incubated maleic acid buffer (DIG Wash 
and Block Buffer Set, Roche). Following blocking (DIG 
Wash and Block Buffer Set, (Roche) in maleic acid buffer 
30  min), the membrane was incubated in anti-Digoxi-
genin-AP, Fab fragments (1:20,000, Sheep, 30 min, Roche, 
RRID:AB_2734716), washed, equilibrated in detection 
buffer and chemiluminescent detection performed using 
CPD star Chemiluminescent Substrate (Roche) on a 
G:box imaging unit (syngene).
Immunoprecipitation and western blotting
Heads were isolated from ~ 1000 Drosophila, per geno-
type, pan-neuronally expressing either UAS-AP1000, 
UAS-GA1000, UAS-PR1000, UAS-GR1000 or UAS-
mCD8-GFP under the control of nSyb-Gal4. Wild type 
controls were Canton-S outcrossed to w1118. Heads were 
lysed in RIPA buffer (10  mM Tris–Cl pH 8.0, 1  mM 
EDTA, 0.5  mM EGTA, 1% Triton X-100, 0.1% Sodium 
deoxycholate, 0.1%SDS, 140  mM NaCl), lysate cleared 
via centrifugation and filtration through 0.45  μm filters 
and diluted to 4 mg/ml. Lysates were incubated with pre-
washed ChromoTek GFP-Trap® magnetic affinity beads 
(30 μl, overnight 4 °C). Beads were then washed and pro-
tein eluted in 4x laemmli buffer. Samples were diluted to 
1 × and run on 4–15% Mini-PROTEAN ® TGX™ Precast 
Gels. Transfers were performed overnight (25  V, 0.02% 
SDS, 10% Methanol, Immobilon-P .45  μm PVDF). Pri-
mary antibodies were anti-GFP (rabbit, abcam, ab290, 
rabbit, abcam, ab290, preabsorbed against Drosophila 
embryos, RRID:AB_303395) and anti-GR repeat (rabbit 
Proteintech, 23978-1-AP). Secondary antibodies were 
HRP conjugated anti-rabbit IgG (Goat, Stratech,111-035-
045-JIR). Blots were imaged using a G:box imaging unit 
(syngene).
Viability and longevity assays
Experimental crosses for viability were designed to give 
a 50:50 ratio of offspring either expressing the DPR con-
struct or carrying the DPR but no driver (undriven sib-
lings) (Fig.  2a). The number of F1 offspring eclosing as 
adults was scored as a readout of adult viability. Driv-
er’s used were either nSyb-Gal4 (RRID:BDSC_51635), 
for pan-neuronal expression, or Tubulin-Gal4 
(RRID:BDSC_5138), for global expression. For longev-
ity assays male flies were kept in vials of ~ 10 per vial and 
survival scored each day. Flies were transferred onto new 
food every 3  days. Kaplan–Meier survival curves were 
plotted using the survival analysis function in GraphPad 
Prism 8. Significance was determined using a Log-Rank 
(Mantel-Cox) test with Bonferroni correction for multi-
ple comparisons.
Ex vivo immunohistochemistry
Drosophila larval dissections were performed as 
described previously [34]. Neuromuscular Junction 
(NMJ) immunohistochemistry and analysis was per-
formed as described previously [34]. Larval salivary 
glands were dissected in PBS and fixed for 7  min in 
3.7% formaldehyde in PBS. Adult brains were dissected 
at 7  days post-eclosion, unless otherwise stated, and 
fixed for 1  h in 3.7% formaldehyde in PBS. Brains were 
washed 3 times in PBS-T (0.5% Triton X-100). Poly-
GR and Poly-PR were labelled with anti-GFP (1:1000, 
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rabbit, abcam, ab290, preabsorbed against Drosoph-
ila embryos, RRID:AB_303395). Additional primary 
antibodies were anti-TAR DNA-Binding Protein-43 
Homologue (TBPH) (Drosophila TAR DNA-Binding 
Protein-43 (TDP-43), 1:500, Rabbit [38]), anti-elav 
(1:50, Mouse, DSHB, RRID:AB_2314364), anti-Cleaved 
Caspase 3 (1:200, rabbit, Cell Signalling Technol-
ogy, 5A1E, RRID:AB_2070042), anti-bruchpilot (1:50, 
mouse, DSHB, RRID:AB_2314866), Cy3-conjugated 
anti-HRP (1:200, goat, Jackson Immuno-Research, 
RRID:AB_2338959). Secondary antibodies used were 
anti-Rabbit IgG (H + L) Alexa Fluor 488 (1:1000, 
RRID:AB_2576217, goat) and anti-mouse IgG (H + L) 
Alexa Fluor 594 (1:1000, RRID:AB_2534091, goat). Tis-
sues were mounted in Vectashield Hardset mounting 
medium (RRID:AB_2336787). Imaging was performed 
using a Leica DM6000 B Microscope using a Hamamatsu 
ORCA-R2 C10600-10B-H camera. NMJ structural imag-
ing was performed using the QIOPTIQ Optigrid Struc-
tured Illumination module on the same Leica DM6000 B 
Microscope. Cleaved Caspase 3 (CC3) quantification was 
performed by counting the number of CC3 positive cells 
throughout whole brains imaged with identical settings 
(2 μm z-interval), in at least 3 animals per genotype.
Quantification of the number of neurons in the central 
brain containing DPRs was performed by counting the 
number of elav positive neurons that were also GFP posi-
tive. 300 neurons within one hemisphere were counted 
from whole brains imaged with identical settings (2 μm 
z-interval), in at least 5 animals per genotype Quantifi-
cation of active zones at the Drosophila larval NMJ was 
performed by counting the number of nc82/bruchpilot 
positive spots present within boutons of the muscle 6/7 
hemi-segment A3 NMJ of third instar wandering larvae. 
Quantification was performed from NMJs imaged using 
identical settings with a 1 μm z-interval, from at least 5 
animals per genotype. Salivary glands for TBPH/TDP-43 
analysis were imaged using a Leica SP5 confocal micro-
scope with an HCX PL APO CS 40.0x1.30 oil objective. 
Nuclear and cytoplasmic TBPH/TDP-43 fluorescence 
intensity was quantified relative to controls using imageJ 
from 25  μm z-stacks (0.5  μm z-interval) imaged using 
identical settings. 20 cells per animal, 3 animals per geno-
type from independent crosses were quantified.
Primary neuronal cultures
Primary neuron cultures were generated following proce-
dures described previously [21, 22, 27]. Briefly, embryos 
were dechorionated using bleach, selected at approxi-
mately stage 11, sterilized with ethanol and mechani-
cally dissociated. Cells were then chemically dispersed, 
washed in Schneider’s medium with 20% fetal calf serum 
and plated onto concanavalin A (5  μg/ml) coated glass 
coverslips. Coverslips were kept on custom incuba-
tion chambers, where cells were grown as hanging-drop 
cultures at 26  °C for 3–10  days in  vitro (DIV). Primary 
neurons were fixed in 4% paraformaldehyde (PFA) in 
0.1  M phosphate-buffered saline (PBS; pH 6.8 or 7.2) 
for 30 min at room temperature and then washed three 
times in PBS with 0.3% Triton X-100 (PBT), followed 
by staining. Antibody staining and washes were per-
formed in PBT using anti-tubulin (clone DM1A, mouse, 
Sigma-Aldrich, 1:1000, RRID:AB_477583) and anti–
GFP (ab290, rabbit, abcam, 1:1000, RRID:AB_303395). 
Secondary antibodies were anti-rabbit Alexa Fluor 
488 (1:1000, RRID:AB_2576217, goat) and Cy3-conju-
gated anti-mouse (1:200; Jackson Immuno-Research, 
RRID:AB_2315777, donkey). Culture slides were 
mounted in ProLong Gold.
Histology
28  days post-eclosion Drosophila heads were removed 
and fixed in 3.7% formaldehyde in PBS + 0.1% tween, 
4  °C with rotation. Heads were dehydrated and infil-
trated using a graded series of ethanol:Infiltration solu-
tion (50:50, 25:75, 10:90, 0:100 × 3, 30 min 4 °C followed 
by 0:100 for 48 h 4 °C with rotation, (Infiltration solution: 
2.5% catalyst in JB-4 Solution A (w/v), Sigma EM0100)). 
Heads were embedded (1:25 accelerator:infiltration solu-
tion) in polyethylene embedding moulds with embed-
ding stubs and left to polymerise at 4  °C. Heads were 
sectioned at 4  μm intervals using tungsten blades on a 
Leica RM2255 microtome. Hematoxylin and eosin (H&E) 
staining and coverslipping was performed using a Leica 
ST5010 Autostainer XL. Sections were imaged using 
H&E autofluorescence in the 633 nm channel on a Leica 
DM6000 B Microscope using a Hamamatsu ORCA-R2 
C10600-10B-H camera. Quantification was performed by 
measuring the diameter of all vacuoles within a defined 
500 μm area. Measurements were taken across multiple 
sections covering the same region of the brain and from 
at least 3 animals per genotype.
Electrophysiology
Electrophysiological recordings were carried out at room 
temperature in third instar wandering larvae. Larval dis-
section and electrophysiological recordings were per-
formed in HL3 saline (70 mM NaCl, 5 mM KCl, 20 mM 
 MgCl2 hexahydrate, 10 mM  NaHCO3, 115 mM Sucrose, 
5  mM HEPES, 1.5  mM  CaCl2). Borosilicate glass elec-
trodes (GC100F-10; Harvard Apparatus) were pulled to 
a resistance of 25-35  MΩ (Flaming brown micropipette 
puller, P-97; Sutter Instruments) and back filled with 
3  mM KCL. Intracellular recordings were performed 
on muscle 6 of segments A3-4 using an AxoClamp-2B 
amplifier controlled by pClamp (version 10.3) with a 
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Digidata 1322A analogue–digital converter (Molecular 
Devices, Axon Instruments). Frequency and amplitude of 
mEJP events was calculated using MiniAnalysis (v6.0.7, 
Synaptosoft), with mEJP events selected manually. Input 
Resistance  (Ri) and EJP amplitude calculated using 
Clampfit (v10.6, Axon Instruments).
Motor assays: negative geotaxis
Male flies were placed individually, without anestheti-
sation, inside glass boiling tubes mounted on a white 
background. After acclimatisation the flies were banged 
down to the bottom of the tubes to elicit the startle-
induced negative geotaxis escape behaviour. Videos were 
recorded until all flies reached the top or for a maximum 
of 90 s. Videos were processed using imageJ and custom 
macros. Briefly videos were batch thresholded and a cus-
tom macro used to track the movement of individual flies 
between frames (30 frames per second), via the MTrack2 
plugin, and plot the position of the flies. These data were 
then used to determine the median speed of each fly. The 
assay was performed at 25 °C. To prevent circadian differ-
ences the assay was always performed at the same time of 
day, within an hour window. For co-expression of DPRs 
the slightly weaker pan-neuronal nSyb-Gal4 driver on the 
second chromosome was used. All other aspects of the 
assay were the same. Motor assays were performed using 
flies from at least 3 independent crosses per genotype.
Genetic interaction studies: eye screens
The glass multimer reporter (GMR) Gal4 line was used 
to express the UAS-DPR-EGFP constructs specifically 
within the fly eye. Eye phenotypes were scored between 
1 and 3  days post-eclosion using an 8 point classifica-
tion system modified from that previously described by 
Pandey et  al.,(2007), Ritson et  al., (2010) and He et  al., 
(2014) [8, 20, 24]. 1 point was awarded for each of the 
following categories: Alterations to eye size, gross mor-
phological disruption to the eye, super-/supra-numerary 
interommatidial bristles, abnormal interommatidial bris-
tle orientation, disorganisation of the ommatidial array, 
ommatidial fusion, pigmentation defects and the pres-
ence of melanised patches. Pharate lethality scored 9. 
Each fly was awarded a final score between 0 and 9. 
Graphs show the percentage of flies scoring each value. 
The mean score per genotype is also shown. Flies were 
scored from a minimum of 3 independent crosses per 
genotype. Eyes were imaged using a Zeiss Z.1 lightsheet 
confocal using the autofluorescence from the flies cuti-
cle in the 488  nm wavelength. Whole flies were fixed, 
mounted in 1% low melting point agar and the lightsheet 
sample chamber filled with PBS. Samples were imaged 
using a 5x objective with 2x zoom.
qRT‑PCR
RNA was extracted from 10 larval brains (L3 stage) or 
adult heads per biological repeat. All reactions were run 
in duplicates for three to five independent biological 
repeats per genetic condition. Tissues were snap frozen 
and processed via standard TRIzol-chloroform extrac-
tion. cDNA and minus-reverse transcriptase controls 
were synthesised from 1 µg of RNA using the Quantitect 
cDNA synthesis kit (Qiagen), following the manufactur-
er’s instructions. PCR reactions for realtime qRT-PCR 
contained Power SYBR Green master mix (Applied Bio-
systems), 10 ng cDNA template (water for negative con-
trols) and 250  nM primer mix in 20 uL volume. They 
were run in a Biorad CFX96 PCR machine and analysed 
using CFX Manager software (Biorad). To detect the 
expression of UAS constructs, a primer binding in the 
common 5’ region of all pUAST-derived transcripts was 
used. The expression of mEFTu1 and Rpl32 was used as 
reference. Relative expression levels were derived from 
CFX-Manager and normalised to the median of biologi-
cal repeats of AP1000 (when comparing different DPR-
1000s and GR-50) or AP36 (when comparing APs of 
different lengths). Graphs depict ΔCT values and nor-
malised relative expression levels of biological repeats 
showing median values of biological repeats with 95% 
confidence interval range (whiskers) and data-points 
depict mean values from technical duplicates from each 
biological repeat. Data were analysed for expression dif-
ferences via ANOVA with Tukey’s multiple comparison 
post hoc analysis on ΔCT values [37] (GraphPad Prism). 
Primers used were mEFTu1 forward: CAT GTC CTT CAT 
CCA ACT GCA, reverse: AAT GAG CTT GGT GTC TTC 
GCC, Rpl32 forward: GCT AAG CTG TCG CAC AAA TG, 
reverse: GTT CGA TCC GTA ACC GAT GT and UAS for-
ward: ACC AGC AAC CAA GTA AAT CAAC, reverse: ATT 
CCC AAT TCC CTA TTC AGAG.
Statistics and graphics
Statistical analysis and generation of graphs was per-
formed using Prism 8.3.0 (Graphpad). With the exception 
of graphs for qRT-PCR data, which show 95% confidence 
intervals, all error bars represent SEM. Figures were 
assembled using Adobe Illustrator (2019, version 23.1.1). 
The Drosophila “genotype builder” [26] was used with 
Adobe Photoshop (2019, version 21.0.1) to generate 
Drosophila “cartoons” in Fig. 2.
Results
Expression of stable, physiologically relevant repeat length 
DPRs in Drosophila
In order to investigate the effect physiologically rel-
evant repeat length DPRs have in an in  vivo context, 
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Drosophila lines expressing DPRs with over 1000 repeats 
were generated (see materials and methods). The UAS/
Gal4 system was used to allow cell- or tissue-specific and 
temporal control of DPR expression. Having observed 
repeat instability in a number of previous DPR models 
Southern blots were performed routinely, every couple of 
months, in order to confirm both the presence and stabil-
ity of each DPR. At 12 months after the initial transfor-
mants were identified (~ 30 generations) DPR constructs 
were shown to be present at full length, relative to both 
the predicted size and the positive controls (Fig.  1a). 
Blots show stocks derived from two independent trans-
formants per DPR genotype (Fig. 1a). Initial screens look-
ing to identify which potential transformants contained 
full length DPRs revealed multiple lines of each genotype 
containing DPRs at a length comparable to the positive 
control (Additional file  1: Online resource 3). qRT-PCR 
confirmed transgene expression and revealed no signifi-
cant difference in expression levels between the 4 DPR 
lines (AP, GA, PR, GR) (Additional file 1: Online resource 
4). Immunoblotting confirmed pan-neuronal (nSyb-Gal4) 
expression of DPRs resulted in functional expression of 
each DPR transgene, resulting in proteins of comparable 
length to those observed previously when expressed in 
mammalian cell models (Fig. 1b) [2].
Altered longevity, but not viability, in flies pan‑neuronally 
expressing DPRs
Having established Drosophila lines containing stable, 
pathologically relevant repeat length DPRs we asked 
whether pan-neuronal expression of each DPR had a sig-
nificant impact upon survival and/or longevity. Using a 
mating scheme designed to give a 50:50 ratio of pan-neu-
ronally driven DPR offspring to undriven siblings (Fig. 2a) 
the effect of pan-neuronal DPR expression on survival to 
adulthood could be assessed. Pan-neuronal expression of 
DPRs showed no variance from typical mendelian inher-
itance and the 50:50 ratio of driven to un-driven siblings 
observed in controls (Fig. 2b). In contrast global expres-
sion of DPRs using the tubulin-Gal4 driver resulted in 
lethality in both AP and PR lines, as well as a reduced 
viability of GR flies (Additional file 1: Online resource 5). 
Fig. 1 1000 repeat DPRs are stable in the Drosophila Genome at 12 months post‑injection. a Southern blots showing DPR‑EGFP constructs at 
the expected length relative to both positive controls (+) and predicted size. Lanes show ladder, two independent lines per genotype (1 and 2), 
negative controls (−, DNA from wild type flies) and positive controls (+, DNA from wild type flies spiked with 1000 repeat DNA). b Immunoblots 
showing DPR constructs are expressed within the Drosophila nervous system. DPRs were detected with either anti‑GFP (AP1000, GA1000 and 
PR1000) or anti‑GR. Asterisks show DPR bands
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Global expression of GA showed no detrimental effect 
on viability. Having demonstrated pan-neuronal expres-
sion of DPRs to be adult viable we investigated whether 
expression of 1000 repeat length DPRs had an impact 
on longevity. Consistent with previous findings expres-
sion of GR significantly impaired longevity compared to 
wild type and GFP controls (p < .001) (Fig. 2c and Addi-
tional file 1: Online resource 6). Pan-neuronal expression 
of either AP1000 or GA1000 resulted in a subtle, but sig-
nificant increase in longevity (p < .001 and p < .01, respec-
tively) (Fig. 2c and Additional file 1: Online resource 6).
DPRs show distinct localisation patterns 
within the Drosophila nervous system
Pan-neuronal expression of DPRs led to the localisa-
tion of DPRs throughout the CNS of both Drosophila 
adults (Fig. 3a) and larvae (Fig. 3b). While pan-neuronal 
expression of the GFP control (mCD8-GFP) (Additional 
file  1: Online resource 7) resulted in GFP localisation 
throughout the nervous system, each DPR showed a dis-
tinct localisation pattern. AP and GA were largely con-
fined to the central brain, whilst PR and GR could be 
observed throughout both the central brain and optic 
lobes (Fig. 3a). DPRs were not found in every cell under 
the control of the pan-neuronal driver (Fig. 3 and Addi-
tional file 1: Online resource 7). While 100% of neurons 
(elav positive) in the adult central brain of control flies 
expressed mCD8-GFP DPRs were only observed in AP: 
47 ± 4.07%, GA: 18.8 ± 3.28%, PR: 39.7 ± 3.16% and GR: 
42.8 ± 1.4% of elav positive neurons in DPR expressing 
flies (n = 300 neurons per brain, N = 5 brains per geno-
type) (Additional file  1: Online resource 7d). DPR mor-
phology and intracellular localisation closely resembled 
that seen in post-mortem patient brains [14, 18]. For 
Fig. 2 Pan‑neuronal expression of 1000 repeat DPRs alters longevity but not viability. a Mating scheme for Drosophila viability assays. Flies 
homozygous for the UAS‑GFP‑DPR constructs were crossed to flies carrying the pan‑neuronal driver (nSyb‑Gal4) over the Tm6b balancer 
chromosome. Normal mendelian inheritance should result in a 50:50 ratio of flies carrying both the driver and DPR (pan‑neuronally driven DPR) 
and those carrying only the DPR in the absence of the driver (undriven siblings). b pan‑neuronal expression of each DPR line following the mating 
scheme in “a” shows no significant variance in viability compared to GFP (mCD8‑GFP) controls or to the expected 50:50 ratio. Two independent lines 
of each DPR are shown. N is shown above each bar. c flies pan‑neuronally expressing GR1000 show a significant reduction in longevity compared to 
wild type and control flies (Survival Log‑Rank (Mantel‑Cox) with Bonferroni Correction, *** p < .001 (See Additional file 1: Online resource 6)). N: wild 
type (WT) = 96, GFP = 98, AP = 100, GA = 111, PR = 119, GR = 90. All flies in “b” and “c” were collected from at least 3 independent crosses
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example, AP and GA were predominantly observed as 
peri-nuclear cytoplasmic aggregates, with GA forming 
characteristic stellate structures. AP was also observed 
as diffuse granular cytoplasmic “pre-inclusion”, simi-
lar to that observed in post-mortem patient tissues [14, 
18]. Both adult and larval brains revealed the occasional 
presence of GA inclusions within neurites. This pheno-
type was more obvious in cultured Drosophila primary 
neurons (Fig.  3c). Diffuse cytoplasmic staining spread-
ing into neurites was also observed in some primary 
neurons expressing AP, PR and GR. PR was observed to 
be nuclear and cytoplasmic in both ex  vivo Drosophila 
brains and primary neurons. These results are compa-
rable to those observed previously is SH-SY5Y cells and 
patient tissue [2, 28]. GR showed nuclear and cytoplas-
mic localisation similar to that observed in post-mortem 
patient tissue [28]. Nucleolar DPR localisation was not 
typically observed.
Altered TDP‑43 localisation in DPR expressing flies
In addition to the accumulation of DPR aggregates, 
C9orf72-related FTD/MND is characterised by perturbed 
Fig. 3 Pan‑neuronal expression of DPRs reveals distinct localisation and inclusion morphology within the Drosophila nervous system. a 
Pan‑neuronal (nSyb‑Gal4) expression of EGFP‑tagged DPRs in the Drosophila adult brain (7 days post‑eclosion). Scale bars 100 μm main panel, 
20 μm zoom b Pan‑neuronal (nSyb‑Gal4) expression of EGFP‑tagged DPRs in the Drosophila larval central nervous system. Scale bars 20 μm. 
Neuronal nuclei are labelled with Anti‑elav (magenta) in (a) and (b). c Primary neurons isolated from Drosophila embryos. Neurons were co‑labelled 
with anti‑tubulin (magenta). Scale bars 25 μm
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nuclear-cytoplasmic localisation of TDP-43. Altered 
localisation and aggregation of TDP-43 is a major patho-
logical hallmark across the FTD/MND spectrum. While 
the pathogenic mechanisms by which TDP-43 leads to 
neurodegeneration remain unclear, recent studies suggest 
that accumulation of soluble cytosolic TDP-43 may drive 
toxicity in C9orf72 related FTD/MND, irrespective of the 
formation or insoluble TDP-43 inclusions [13]. Cytosolic 
accumulation of TDP-43 may be the result of, and further 
potentiate, nuclear cytoplasmic transport defects [11, 29, 
39]. In a recent study Solomon et al. (2019) demonstrated 
that DPRs, not RNA accumulation, led to cytoplasmic 
mislocalisation of the Drosophila TDP-43 homologue 
TBPH [29]. They also demonstrated that due to their 
large size Drosophila salivary glands provide a robust 
model for quantification of the nuclear-cytoplasmic 
localisation TDP-43/TBPH [29]. This approach was used 
to elucidate whether 1000 repeat DPRs perturbed normal 
TDP-43/TBPH localisation. While expression of AP1000 
and GA1000 showed no significant alteration to TDP-43/
TBPH localisation, compared to GFP controls, expres-
sion of PR lead to a small, but not significant increase in 
the percentage of TDP-43/TBPH localising to the cyto-
plasm (Fig.  4a, b). Expression of GR1000 resulted in a 
significant mislocalisation of TDP-43/TBPH to the cyto-
plasm (Fig. 4a, b). Quantification of the number TDP-43/
TBPH inclusions revealed only GA expression increased 
inclusion formation (Fig.  4c), supporting previous find-
ings [11]. In addition, 53% of TBPH inclusions colocal-
ised with GA aggregates (27 of 51 inclusions, 60 cells, 3 
animals) (Fig. 4d). This represents 18% of GA aggregates 
colocalising with TDP-43/TBPH (27 of 148 aggregates). 
There was no clear colocalization between TDP-43/
TBPH and other DPRs.
Pan‑neuronal expression of DPRs leads 
to neurodegeneration and cell death in the Drosophila 
central brain
In order to establish whether expression of DPRs in the 
Drosophila nervous system resulted in hallmarks of neu-
rodegeneration histological analysis was performed. His-
tological examination of Drosophila brains at 28  days 
post-eclosion reveals characteristic neurodegenerative 
vacuolar regions throughout the fly brain (Fig. 5a). Quan-
tification reveals a significant increase in the number 
of vacuoles greater than 5  μm in flies expressing either 
AP1000 or GR1000 (p < .0001 and p < .001), compared 
to age matched wild type controls (Fig. 5c). AP1000 and 
Fig. 4 TDP‑43/TBPH mislocalisation in DPR expressing Drosophila. a TDP‑43/TBPH (magenta) and DPR (green) localisation in Drosophila Salivary 
glands. Scale bars 50 μm boxed region expanded in (d). b Quantification of the percentage of TDP‑43/TBPH localising to the nucleus or 
cytoplasm (60 cells from 3 animals, from 3 independent crosses, per genotype). c Quantification of the percentage of DPR containing cells with 
insoluble TDP‑43/TBPH inclusions. Total number of DPR containing cells (n) are shown on bars, total number of animals (N) = 3 per genotype. d 
co‑localisation of TDP‑43/TBPH and PolyGA aggregates
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GR1000 brains also showed a significant number of vacu-
oles greater than 10 μm in diameter (p < .0001 and p < .05) 
(Fig. 5d). The number of apoptotic cells was significantly 
increased in brains for all four pan-neuronally expressed 
DPRs, compared to age matched wild type controls 
(Fig. 5b, e). Taken together these results reveal all DPRs 
drive some degree of cell death and neurodegeneration 
within the Drosophila nervous system, although pheno-
types differ between DPR species.
DPR specific aberrations to neuronal structure 
and function
The Drosophila third instar larval neuromuscular junc-
tion (NMJ) is a well characterised model synapse with 
Fig. 5 Histological analysis of Drosophila adult brains pan‑neuronally expressing DPRs. a Histological sections of adult Drosophila brains at 28 days 
post‑eclosion reveals vacuolar holes (examples labelled with arrows), characteristic of neurodegeneration in the Drosophila central nervous 
system. Scale bars 100 μm. b at 28 days post‑eclosion pan‑neuronal expression of DPRs results in a clear increase in the number of cells positive 
for the apoptotic marker cleaved caspase 3 (CC3) (arrows show examples), compared to age matched control (mCD8‑GFP) flies. Scale bars 50 μm. 
c, d Quantification of the number of vacuoles > 5 μm (c) and > 10 μm (d) reveals a significant increase in the number of vacuoles in flies 28 days 
post‑eclosion pan‑neuronally expressing (nSyb‑Gal4) UAS‑AP1000 and UAS‑GR1000, compared to age‑matched controls (ANOVA with post hoc 
Dunnett’s multiple comparison to wild type controls ****p < .0001,; ***p < .001 ; *p < .05) n = 3 brains per genotype. e Quantification of the number 
of CC3 positive cells within central brain of adult Drosophila pan‑neuronally expressing (nSyb‑Gal4) DPRs at 28 days post‑eclosion. (ANOVA with 
post hoc Dunnett’s multiple comparison to wild type controls ****p < .0001; ***p < .001; **p < .01). n is shown on bars
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significant structural and functional similarity to ver-
tebrate central synapses [15, 33, 34]. As a result, it has 
become a well-established tool for the study of neuronal 
structure and function in Drosophila models of neurode-
generation [33–36]. Morphological analysis of the NMJ 
at muscle 6/7 hemi-segment A3 revealed pan-neuronal 
expression AP1000 results in a significant reduction in 
NMJ length, (p < .001) coupled with a reduction in the 
number of bruchpilot/nc82 positive active zones (p < .05), 
when compared to wild type (Fig. 6). Total bouton num-
ber and muscle size was unaffected. While pan-neuronal 
expression of GA1000 showed no significant variance to 
wild type in terms of NMJ length, bouton number, muscle 
size or number of active zones pan-neuronal expression 
of GR1000 resulted in a significant reduction in muscle 
size (p < .01). PR1000 expression increased the number of 
active zones at the NMJ (p < .01) (Fig. 6). Taken together 
these observations suggests expression of each DPR may 
lead to different perturbations of molecular mechanisms, 
resulting in the unique phenotypic profiles observed with 
each DPR.
Previously we demonstrated a length dependent 
decrease in spike amplitude in differentiated SH-SY5Y 
cells transfected with increasing repeat lengths of Pol-
yAP [2]. Having observed a significant decrease in both 
NMJ length and active zone number in Drosophila lar-
vae pan-neuronally expressing AP1000 we asked whether 
these larvae showed impaired electrophysiological func-
tion. Pan-neuronal expression of AP1000 led to a sig-
nificant (p < .01) 31% reduction in Excitatory Junction 
Potential (EJP) amplitude, compared to controls (Fig. 7a), 
consistent with the 27% reduction in active zone num-
ber observed in these animals (Fig. 6d). AP1000 express-
ing larvae also showed a significantly reduced input 
Fig. 6 Morphological analysis of the Drosophila larval neuromuscular junction. a Micrographs showing the neuromuscular junction (NMJ) (muscle 
6/7 hemi‑segment A3) of third instar larvae pan‑neuronally expressing (nSyb‑Gal4) DPRs. Anti‑HRP labels the nervous system (magenta) and 
anti‑bruchpilot (Brp/nc82) active zones (green). Scale bars 10 μm. Quantification of b NMJ length, c muscle surface area, d bouton number and e 
active zone number. ANOVA with post hoc Dunnett’s multiple comparison to wild type controls ***p < .001; **p < .01; *p < .05. The number of NMJ’s 
analysed are shown on each graph. NMJs were quantified from at least 8 animals (N = 8) taken from at least 3 independent crosses per genotype
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resistance (Fig.  7b) (p < .05), but no variance in quantal 
size (mEJP amplitude) (Fig. 7c), mini-frequency (Fig. 7d) 
or quantal content (Fig. 7e). Pan-neuronal expression of 
the other DPRs resulted in no significant variance in elec-
trophysiological profiles when compared to controls, or 
each other.
Pan‑neuronal expression of arginine positive DPRs leads 
to an age related decline in motor function
One of the limitations of the Drosophila larvae as a 
model system is its limited capacity in the study of age-
ing. In order to characterise the phenotypic profiles of 
each DPR in an ageing in  vivo system the motor func-
tion of adult flies pan-neuronally expressing DPRs was 
analysed throughout the fly’s lifetime. Semi-automated 
tracking was used to ascertain the median speed of 
flies during startle-induced negative geotaxis assays, 
providing a proximal readout of motor function dur-
ing ageing. Early in life, up to 3 days post-eclosion, only 
pan-neuronal expression of AP1000 showed any signifi-
cant decline (p < .0001) in climbing speed, compared to 
age-matched controls (Fig.  8a). By 7  days post-eclosion 
GA1000 flies also showed a significant reduction in speed 
(p < .05) (Fig. 8a, b). At 28 days both AP1000 and GR1000 
expressing flies showed significantly impaired climb-
ing speed, compared to age-matched controls (Fig.  8a, 
b). While both AP1000 and GA1000 expressing flies 
showed impaired climbing by 7 days they showed no sig-
nificant further reduction in motor function by 28  days 
(Fig.  8a, b). In contrast PR1000 and GR1000 expressing 
flies, which showed no variance to wild  type at 7  days, 
displayed a significant decline in motor function from 7 
to 28 days post-eclosion. As expected wild type and GFP 
control flies showed a slight, but non-significant, decline 
in climbing speed with age. The number of flies assayed 
at each time point in Fig. 8a is shown in Additional file 1: 
Online resource 8. These observations demonstrate 
each DPR to exhibit a distinct temporal phenotypic pro-
file, with each capable of contributing towards impaired 
motor function in ageing Drosophila.
Co‑expression of DPRs results in novel, combination 
specific, phenotypic profiles
In order to ascertain whether DPRs act synergistically 
to contribute to toxicity in these Drosophila models we 
utilised the Drosophila eye as a robust, high-throughput, 
system to screen for modification of DPR toxicity. Het-
erozygous expression of each DPR in the Drosophila eye, 
Fig. 7 Electrophysiological analysis of DPR expressing larvae. a Excitatory junction potential (EJP) amplitude, b input resistance (Ri), c mini‑EJP 
(mEJP) amplitutde, d mEJP frequency and e Quantal Content measured at muscle 6 (hemi‑segment A3/4) of third instar wandering larvae 
pan‑neuronally expressing (nSyb‑Gal4) DPRs or an mCD8‑GFP control. f representative traces showing evoked (EJP) (top traces) and spontaneous 
(mEJP) (bottom traces) responses in control (mCD8‑GFP) and AP1000 larvae. n’s are shown on each graph. Recordings were made from at least 5 
animals (N = 5) taken from at least 3 independent crosses per genotype
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under the control of the eye specific driver GMR-Gal4 
at 25  °C, resulted in a very mild rough eye phenotype 
in a small percentage of flies expressing alanine positive 
DPRs (Fig.  9). No flies heterozygously expressing argi-
nine positive DPRs showed any variance to wild  type 
(Fig. 9). Increasing the expression of the UAS-Gal4 sys-
tem and therefore the dose of DPR, by raising flies at 
29  °C resulted in a more severe phenotype than when 
expressed heterozygously at 25 °C, with all DPRs exhibit-
ing a mild rough eye phenotype (Additional file 1: Online 
resource 9). Increasing the expression levels of the 
DPRs further through homozygous expression at 25  °C 
resulted in a significantly more perturbed eye phenotype 
in all DPRs, except for GA (Fig. 9). When homozygously 
expressed arginine positive DPRs showed greater toxicity 
than alanine positive DPRs, demonstrating the differen-
tial effect of expression levels upon the toxicity of differ-
ent DPR species, at least on the eye phenotype.
While homozygous expression of most individual DPRs 
resulted in a significant enhancement of toxicity observed 
in the eye, heterozygous co-expression of two different 
DPRs led to a significant enhancement of the eye phe-
notypes only in specific combinations (Fig.  9). Toxic-
ity associated with co-expression was typically less than 
seen through homozygous expression of most single DPR 
species. However, it was observed that co-expression of 
GR with any of the other DPRs resulted in a potentiation 
of the eye phenotype, compared to heterozygous controls 
or co-expression of other DPR species. Co-expression 
of PR and AP with each other or GR resulted in a more 
severe eye phenotype. Co-expression of PR and AP with 
GA showed no significant difference to hemizygous or 
homozygous expression of GA alone (Fig. 9). Co-expres-
sion of each DPR with a GFP control showed no variance 
to hemizygous expression alone (Fig. 9).
Having shown DPR expressing flies to display age-
dependent phenotypes, and given the limitations of the 
fly eye as a model to look at ageing, we asked whether 
combining specific DPRs had any affect upon motor 
function and whether this alters with age (Fig.  10). At 
7  days post-eclosion co-expression of either GA1000 or 
PR1000 with AP1000 showed no significant difference 
to each other, to AP1000 homozygotes, or to wild  type 
(Fig.  10a). In contrast, flies co-expressing GR1000 with 
AP1000 were significantly slower than any other AP1000/
DPR combination or wild types (p < .0001) (Fig.  10a). 
GR1000 expression also potentiated impaired climbing 
ability when co-expressed with GA1000, with GA1000/
GR1000 flies significantly slower than wild  types 
(p < .0001), GA1000/PR1000 (p < .01) and GA1000 
Fig. 8 Age‑related motor impairment in Drosophila pan‑neuronally expressing DPRs. a Median climbing speed of adult Drosophila pan‑neuronally 
expressing (nSyb‑Gal4) either AP1000, GA1000, PR1000, GR1000 or mCD8‑GFP controls. Outcrossed Canton S flies were used as wild type controls. 
Flies were assayed at 3, 7, 14, 21, 28 and 42 days post‑eclosion. Error bars = SEM. At day 3 a minimum of 10 flies per genotype were assayed. The 
minimum number of flies at any time point was 7, resulting from lethality during the time course. For full Ns per time point see the Additional 
file 1: Online resource 8. b Median speed of adult Drosophila pan‑neuronally expressing (nSyb‑Gal4) either AP1000‑GFP, GA1000‑GFP, PR1000‑GFP, 
GR1000‑GFP or mCD8‑GFP or outcrossed Canton S wild type controls at 7 and 28 days post‑eclosion. Error bars = SEM. ANOVA with post hoc 
Dunnett’s multiple comparison to wild type controls ****p < .0001; *p < .05 and Tukey’s multiple comparison between groups (time points) 
####p < .0001; ##p < .01. N’s are shown on the graph. Flies for motor assays were from at least 3 independent crosses per genotype
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homozygotes (p < .01) (Fig.  10b). GA1000/AP1000 and 
GA1000/PR1000 combinations showed no significant 
variance to wild type, at 7 days (Fig. 10b). At 7 days post-
eclosion GR1000/AP1000 flies were significantly slower 
than those co-expressing GR1000 with either GA1000 
or PR1000 (Fig. 10d). Co-expression of PR1000 with any 
other DPR, including GR1000, showed no significant 
variance from wild  type (Fig.  10c). Flies pan-neuronally 
expressing either GR1000 or PR1000 homozygously were 
not adult viable, supporting our previous observations 
in the fly eye that homozygous expression of the argi-
nine rich DPRs showed significant toxicity. By 28  days 
post-eclosion all DPR combinations showed significant 
impairment to motor function, compared to wild  type 
(Fig. 10e–h). Co-expression of GR and AP was lethal by 
28 days, the only non-homozygous combination to show 
lethality. AP1000/GA1000 and GA1000/GA1000 express-
ing flies were significantly faster than all other DPR com-
binations, suggesting these combinations are not as toxic 
as those combinations expressing arginine positive DPRs. 
Fig. 9 DPR‑DPR modifier screens: co‑expression of DPRs in the Drosophila Eye. a lighsheet micrographs showing the eye of flies homozygously 
expressing DPRs under the control of a single copy of the eye specific driver GMR‑Gal4 (GMR‑Gal4/+). Scale bars 100 μm. b Quantification of the 
eye phenotypes in flies co‑expressing DPRs, compared to heterozygous and homozygous expression of single DPR species (see methods for 
classification scoring). Co‑expression of mCD8‑GFP acts as a titration control for GMR‑Gal4. The number of flies scored is shown above each bar. 
Each genotype was scored from a minimum of 3 independent crosses. c Mean overall classification score (± SEM) of genotypes represented in “b”
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Taken together these data reveal distinct age- and com-
bination-specific phenotypic profiles in DPR expressing 
flies.
While performing negative geotaxis assays on aged flies 
co-expressing multiple DPRs it was observed that certain 
combinations exhibited seizure phenotypes in response 
to the startle “bang” stimulus. This phenotype was not 
observed, at any age, in flies expressing single DPRs. At 
7 days post-eclosion only flies co-expressing AP1000 and 
GR1000 presented with seizures, with 33% penetrance. 
By 14  days post-eclosion AP100/GR1000 flies were 
observed to seizure in the absence of a stimulus. These 
flies failed to survive to 28 days post-eclosion. By 28 days 
post-eclosion seizures were also observed in GA1000/
GA1000 (22%), AP1000/PR1000 (40%), GA1000/PR1000 
(29%), GA1000/GR1000 (100%) and GR1000/PR1000 
(71%) flies, in response to a stimulus. Seizures were never 
observed in AP1000/AP1000 or AP1000/GA1000 flies, at 
any age, suggesting seizure phenotypes are unique to spe-
cific DPR combinations.
Discussion
In this study we establish novel Drosophila models of 
C9orf72 related dipeptide-repeats, expressing physi-
ologically and pathologically relevant repeat lengths. 
These models display pathological hallmarks of C9orf72-
related FTD/MND, including the formation of distinct 
DPR aggregates with morphological similarity to those 
observed in patients, as well as altered TDP-43 localisa-
tion. Using these models, we reveal each DPR to exhibit 
a unique, age and assay dependent, pathological and phe-
notypic profile. In addition, we demonstrate that specific 
combinations of DPRs lead to novel, age-dependent, phe-
notypes not observed when DPRs are expressed individu-
ally. Taken together our results provide in  vivo support 
for our previous observations that certain DPRs may only 
show toxicity at a specific length, supporting the hypoth-
esis that DPR toxicity is length dependent [2, 31]. While 
modelling DPRs individually has proven important in 
furthering our understanding of DPR toxicity our results 
reveal that certain phenotypes may not be observed 
unless DPRs are co-expressed. Whilst further investi-
gation will be required to elucidate how DPRs interact 
with each other and how this leads to neuropathology we 
believe this model provides a useful tool for such future 
investigations.
The exact number or repeats required to cause pathol-
ogy has yet to be fully elucidated. However, the majority 
of C9orf72 related FTD/MND cases reported display an 
expansion in the region of 500–4000 repeats [1, 5, 31]. 
Fig. 10 Age‑related motor impairment in Drosophila co‑expressing DPRs. a–d Median climbing speed of adult Drosophila co‑expressing DPRs 
under the control of a single copy of the pan‑neuronal driver nSyb‑Gal4 (nSyb‑Gal4/+) at 7 days post‑eclosion. e–h Median speed of adult 
Drosophila co‑expressing DPRs under the control of a single copy of the pan‑neuronal driver nSyb‑Gal4 (nSyb‑Gal4/+) at 28 days post‑eclosion. 
Error bars = SEM. ANOVA with post hoc Tukey’s multiple comparison between groups ****p < .0001; ***p < .001; **p < .01; *p < .05. Each point 
represents an individual fly. Motor assays were performed from at least 3 independent crosses per genotype
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Whether or not repeat length correlates with age of onset, 
disease severity and progression remain debated, as does 
the contribution of each DPR species to neurotoxicity. 
Despite a number of studies concluding alanine positive 
DPRs show limited toxicity, the majority of these stud-
ies look at repeat lengths below 200 repeats. Previously, 
we demonstrated expression of PolyAP led to a length 
dependent inhibition of action potential amplitude in dif-
ferentiated SH-SY5Y cells [2]. Here we provide support 
for these findings, in a whole organism in  vivo context, 
showing a significant decrease in evoked EJP amplitude 
in Drosophila larvae pan-neuronally expressing AP1000. 
Having observed both structural and functional dysfunc-
tion at the larval NMJ, motor impairment from day 1 
of adulthood and significant neurodegeneration within 
the central brain our data suggests that, if expressed at 
pathologically and physiologically relevant repeat lengths 
throughout life, AP1000 can exhibit a significant basal 
level of toxicity. The same can also be said for GA1000, 
although in this case phenotypes manifest slightly later 
in life, at approximately 7 days post-eclosion. In contrast 
to expression of arginine positive repeats neither AP1000 
or GA1000 expression displayed a significant progres-
sive decline in motor function from the initial baseline 
level of impairment observed between 1 and 7 days post-
eclosion. It was also observed that only GR1000 showed a 
significant detrimental effect upon longevity, suggesting 
that molecular mechanisms underpinning neurodegen-
eration and the characterised functional deficits do not 
necessarily correlate with longevity, at least at the time 
points characterised. As such it is clear that there are dis-
tinct phenotypic profiles associated with each DPR, with 
alanine positive DPRs displaying basal levels of toxicity 
and arginine DPRs presenting with clear age-dependent 
phenotypes.
A number of previous DPR fly models have been 
shown to present with substantial toxicity, displaying sig-
nificantly impaired viability even when expressed solely 
in the fly eye. While these models have played an impor-
tant role is dissecting molecular mechanisms contribut-
ing towards DPR toxicity to date, it may be argued that 
such excessive levels of toxicity are not representative of 
that seen in patients. Here we present a model express-
ing DPRs of a more physiologically relevant repeat 
length that can be pan-neuronal expressed throughout 
the entire lifetime of the fly. This is arguably more rep-
resentative of disease, where patients carry the mutation 
throughout their lifetime with symptoms only develop-
ing with age. Through this approach we have been able 
to dissect subtle, age-related phenotypes including motor 
defects and neurodegeneration. It is important to con-
sider that there are a number of reasons why models 
expressing shorter repeats may show increased toxicity. 
For example, it is well established that the genomic loca-
tion of an inserted transgene can have a significant 
effect on expression levels, dependent upon chromatin 
state and regulator elements local to the insertion [9, 
12]. As such transgenes inserted at different loci are not 
directly comparable. In order to elucidate whether the 
greater levels of toxicity observed in a number of pub-
lished shorter repeat length DPR models, compared to 
the 1000 repeat models described here, related to higher 
expression levels qRT-PCR was used to directly com-
pare expression levels of the constructs in  vivo. qRT-
PCR revealed expression levels in a number of previously 
published shorter repeat models (36, 50 and 100 repeats 
[3, 16]) were no greater than in the 1000 repeat models 
described here (Additional file  1: Online resource 4). 
This observation suggests the greater toxicity observed 
in short repeat models is not due to greater expression 
levels but more likely due to the intrinsic properties of 
the repeats. For example, one must consider that differ-
ent repeat lengths may directly affect the rate of de novo 
synthesis, protein folding and protein–protein interac-
tions, and that this may directly affect toxicity. This will 
be an important line of inquiry for further studies. Hav-
ing observed dose dependent effects of toxicity both 
when expressing 1000 repeat DPRs in the Drosophila 
eye and upon motor function when pan-neuronally 
expressed, it is clear that dosage and expression levels 
do, however, play an important role in DPR toxicity. Our 
observations both in the eye and when pan-neuronally 
expressed also suggest that when expressed at higher 
doses (through homozygous expression) arginine positive 
DPRs are more toxic than alanine positive DPRs. How-
ever, at lower expression levels, particularly in younger 
flies, alanine DPRs appear to show more severe pheno-
types than those expressing arginine positive DPRs. This 
data suggests the importance of both expression levels 
and age when studying DPR toxicity. While it is currently 
not possible to determine whether the expression levels 
of DPRs in our models are comparable to those observed 
in patients the ability to express DPRs over 1000 repeats 
in length pan-neuronally throughout the fly’s lifetime 
suggests the models described here may represent more 
physiologically relevant models of DPRs. Having shown 
that each DPR shows distinct localisation throughout the 
nervous system and that DPRs are not seen in every cell 
under the control of the pan-neuronal driver it may also 
be important to consider whether each DPR has an effect 
on different neuronal-subtypes and whether this effect is 
autonomous or non-autonomous.
The observation that co-expression of arginine and ala-
nine positive DPR species with each other showed a more 
significant, age related, decline in motor function than 
when either arginine or alanine DPRs were co-expressed 
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(e.g. GA + AP, GR + PR) suggests that the progres-
sive degeneration seen in arginine positive DPRs may 
be potentiated by a basal level of dysfunction observed 
through expression of alanine positive species. Impaired 
motor function was most pronounced through co-
expression of GR and AP, with GR1000/AP1000 express-
ing flies significantly slower than any other combination 
at 7  days post-eclosion. This combination was also the 
only one to show stimulus induced seizures at 7  days 
and seizures in the absence of a stimulus at any age. 
GR1000/AP1000 flies also showed premature lethality 
by 28 days, not seen in any other non-homozygous com-
bination. Taken together this data suggest that AP and 
GR may show the most significant pathological interac-
tion. Further investigation will be essential to dissect the 
molecular mechanisms through which this interaction 
may occur and determine the effect this has on the age-
ing nervous system. The identification that specific DPR 
combinations elicit distinct phenotypic profiles, includ-
ing the development of age-related seizure phenotypes 
suggests that studying DPRs in combination may prove 
important in dissecting the molecular mechanisms driv-
ing neuronal dysfunction in FTD/MND.
To date there remains a lack of in vivo models express-
ing C9orf72 related dipeptide repeats with a repeat length 
of more than a few hundred repeats. Whilst these models 
have proven incredibly useful in dissecting the molecular 
mechanisms contributing towards neurodegeneration in 
FTD and MND they may not truly recapitulate the func-
tional and pathological features of longer DPRs observed 
in patients. The model presented here not only highlights 
the potential importance of repeat length, but also of 
studying DPRs in combination and at different ages
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